Trials / Unknown
UnknownNCT02332356
Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Tokyo Medical and Dental University · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, controlled study aims to evaluate the impact of therapeutic intervention (step up) for the patients who are clinical remission with Magnetic Resonance Enterocolonography (MREC) active. In addition, to evaluate the impact of therapeutic step down for the patients who archived clinical and MREC remission. The primary endpoint is the rate of clinical remission at 104 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | azathioprine or adalimumab and infliximab |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
- First posted
- 2015-01-06
- Last updated
- 2023-11-27
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02332356. Inclusion in this directory is not an endorsement.